Where are we with pancreas transplantation?

Area of Science:

• Transplantation immunology and endocrinology.
• Diabetic nephropathy and retinopathy management.
• Graft survival and patient outcomes in diabetes mellitus.

Background:

• Diabetic complications such as nephropathy and retinopathy significantly impact patient quality of life and survival.
• Pancreas transplantation is explored as a therapeutic option to restore endogenous insulin production and halt or reverse diabetic complications.
• Current evidence on the comparative efficacy of combined pancreas-kidney transplantation versus kidney transplantation alone is limited.

Purpose of the Study:

• To evaluate the outcomes of pancreas transplantation, including whole organ and segmental grafts, in patients with diabetes mellitus.
• To compare the survival rates and complication profiles of combined pancreas-kidney transplantation versus kidney transplantation alone.
• To identify patient subgroups who may benefit most from pancreas transplantation.

Main Methods:

• Review of existing literature and clinical data on pancreas and kidney transplantation outcomes.
• Analysis of graft survival rates (1-year) for various transplantation approaches (simultaneous, sequential, segmental, whole organ).
• Assessment of patient survival and complication rates, including ketoacidosis, nephropathy, retinopathy, and neuropathy.

Main Results:

• Simultaneous pancreas-kidney transplantation demonstrates the highest 1-year pancreas graft survival rates (46%-84%).
• Pancreas grafts perform poorly without a simultaneous kidney graft or when performed after a kidney graft.
• Pancreas transplantation improves or stabilizes neuropathy and nephropathy, but does not improve retinopathy; patient survival is linked to ketoacidosis control.

Conclusions:

• Pancreas transplantation, particularly when combined with kidney transplantation, offers significant benefits for select diabetic patients, especially those with end-stage renal disease or at high risk for complications.
• While combined procedures have more complications, they offer the best pancreas graft survival. Patient survival hinges on effective ketoacidosis management.
• Further research is needed to refine patient selection criteria and optimize transplantation techniques, including islet cell transplantation.